Y-Intercept (HK)’s Novavax NVAX Stock Holding History

Y-Intercept (HK)’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$767K	Buy	70,973 +35,131	+98%	+$315K	0.02%	1120
2026 Q2	$338K	Buy	+35,842	New	+$321K	0.01%	1429
2022 Q3	–	Sell	-5,115	Closed	-$263K	–	1180
2022 Q2	$263K	Buy	+5,115	New	+$265K	0.03%	626
2021 Q3	–	Sell	-5,617	Closed	-$1.19M	–	832
2021 Q2	$1.19M	Buy	5,617 +3,454	+160%	+$633K	0.3%	65
2021 Q1	$375K	Buy	2,163 +75	+4%	+$14.9K	0.1%	325
2020 Q4	$248K	Buy	+2,088	New	+$222K	0.1%	375

Other funds holding NVAX

Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return

TSP Capital Management Group Summit, New Jersey $397M AUM 31.23% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return

Independent Financial Group San Diego, California $5.51B AUM 33.51% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Y-Intercept (HK)'s NVAX Position: Q3 2026 in Review

Y-Intercept (HK) increased its Novavax (NVAX) stake by 98% in Q3 2026, buying an estimated $315K and bringing the position to 70,973 shares worth $767K. The position accounts for 0.02% of the portfolio, ranked #1120.

Y-Intercept (HK) first reported a position in NVAX in Q4 2020 and has held it in 6 quarters since. The position peaked at $1.19M in Q2 2021. 56 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.

Y-Intercept (HK) held 70,973 shares of Novavax worth $767K as of Q3 2026.
Y-Intercept (HK) bought 35,131 Novavax shares in Q3 2026, an estimated $315K.
Novavax made up 0.02% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1120 holding.
Y-Intercept (HK) first reported a position in Novavax in Q4 2020 and has held it in 6 quarters since.
Y-Intercept (HK)'s Novavax position peaked at $1.19M in Q2 2021.
56 funds tracked by Wall St. Rank held Novavax as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.